Recursion Pharmaceuticals, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Quarterly earnings show how the company performed and help investors track progress over time.
Companies share earnings updates and presentations so investors can learn about recent performance.
Directors make key company decisions, so shareholders voting on them helps ensure good leadership.
Quarterly earnings show how the company performed and help investors track progress over time.
Companies share earnings updates and presentations so investors can learn about recent performance.
Leadership changes affect company direction, so investors watch for new people taking control.
Chief Medical Officer leads drug development strategy, so this change matters for company direction.
Stocky reads Recursion Pharmaceuticals, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Recursion Pharmaceuticals, Inc.'s most recent tracked filing was a 10-Q on 5 Aug 2026: Reports second quarter 2026 financial results.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.